| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QS | Class A Common Stock | Options Exercise | $5.68K | +4.28K | +2.81% | $1.33* | 157K | Mar 23, 2022 | Direct | |
| transaction | QS | Class A Common Stock | Options Exercise | $23.8K | +10K | +6.37% | $2.38 | 167K | Mar 23, 2022 | Direct | |
| transaction | QS | Class A Common Stock | Sale | -$257K | -14.3K | -8.56% | $18.00 | 153K | Mar 23, 2022 | Direct | F1, F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QS | Stock Option (right to buy) | Options Exercise | $0 | -4.28K | -4.19% | $0.00 | 97.9K | Mar 23, 2022 | Class A Common | 4.28K | $1.33 | Direct | F4 |
| transaction | QS | Stock Option (right to buy) | Options Exercise | $0 | -10K | -3.42% | $0.00 | 282K | Mar 23, 2022 | Class A Common | 10K | $2.38 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2021. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.015, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F3 | Includes 5,294 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Class A Common Stock of the Issuer. 100% of the RSUs vest on the first quarterly vesting date following the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the vesting date. |
| F4 | 20% of the shares subject to the option vested and became exercisable on January 1, 2019, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date. |
| F5 | 20% of the shares subject to the option will vest and become exercisable on December 11, 2020, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date. |